Company IntegraGen

Equities

ALINT

FR0010908723

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Bio Diagnostics & Testing

Real-time Euronext Paris Other stock markets 05:30:51 2024-04-25 am EDT			5-day change	1st Jan Change
0.64 ^EUR	+0.79%		-2.29%	-28.41%

2023	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	IntegraGen SA Announces Revenue Results for the First Half of 2023	CI

IntegraGen specializes in researching and identifying genetic biomarkers and in developing and marketing molecular diagnostic products and services, primarily in the field of oncology. The group's activity is organized around two sectors:

- supply of genomic research services: high-speed genotyping services, medium-speed genotyping services, and ultra-high-speed sequencing services for academic research institutions and pharmaceutical groups;

- sales of diagnostic solutions.

France accounts for 88% of net sales.

Number of employees: 57

EUR in Million	2021	Weight	2022	Weight	Delta
Genetic Biomakers 100.0 %	11	100.0 %	13	100.0 %	+16.27%

EUR in Million	2021	Weight	2022	Weight	Delta
France 100.0 %	11	100.0 %	13	100.0 %	+16.27%

Managers	Title	Age	Since
Bernard Courtieu CEO	Chief Executive Officer	60	07-09-05
Pierre Flamant DFI	Director of Finance/CFO	-	-
Francois Degrave CTO	Chief Tech/Sci/R&D Officer	-	-
Emmanuel Martin COO	Chief Operating Officer	-	06-06-30
Jean-Pol Detiffe BRD	Director/Board Member	51	-
Manuelle Puissant HRO	Human Resources Officer	-	-
Berengere Genin PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Baron Jean Stéphenne CHM	Chairman	73	-
Jean-Pol Detiffe BRD	Director/Board Member	51	-
Emmanuelle Deponge BRD	Director/Board Member	-	18-06-13
Bernard Courtieu CEO	Chief Executive Officer	60	07-09-05
François Blondel BRD	Director/Board Member	60	-
Alain Declercq BRD	Director/Board Member	44	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	6,727,332	2,218,298 ( 32.97 %)	76,063 ( 1.131 %)	32.97 %

Name	Equities	%	Valuation
Trusteam Finance SCA 1.741 %	117,117	1.741 %	90 058 €
BNP Paribas Cardif SA 0.2334 %	15,700	0.2334 %	12 073 €
Génération Vie SA 0.0268 %	1,800	0.0268 %	1 384 €
Allianz Global Investors GmbH (France) 0.007432 %	500	0.007432 %	384 €

IntegraGen SA

5, rue de Henri Desbruères Génopole Campus 1, Genavenir 8

91000, Evry

+33 1 60 91 09 00

http://www.integragen.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
INTEGRAGEN	-28.41%	4.5M
EXACT SCIENCES CORPORATION	-14.52%	11.48B
IOVANCE BIOTHERAPEUTICS, INC.	+44.03%	3.27B
GUARDANT HEALTH, INC.	-33.09%	2.2B
BGI GENOMICS CO., LTD.	-18.60%	2.05B
VERACYTE, INC.	-27.59%	1.49B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+17.10%	1.01B
SEEGENE, INC.	-3.06%	743M
CAREDX, INC	-33.50%	413M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-46.94%	377M

Bio Diagnostics & Testing